Impact of COVID-19 and lockdown regarding blood transfusion.
Xavier DelabrancheDaniel KientzCharles TacquardFrançoise BertrandAnne-Claude RochePierre Tran Ba LocCatherine HumbrechtFlorian SirlinXavier PivotOlivier CollangeFrançois LevyWalid OulehriChristian GachetPaul-Michel MertesPublished in: Transfusion (2021)
Reduction of admissions due to SARS-CoV-2 pandemic results only in a moderate decrease of blood transfusion. Incompressible blood transfusions concern urgent surgery, acute bleeding (including some patients with COVID-19, especially under high anticoagulation), or are supportive for chemotherapy-induced aplasia or chronic anemia. Lockdown results in a decrease of blood donation by cancellation of mobile donation but with little impact on a short period by mobilization of usual donors. No mismatch between demand and donation was evidenced and no planned restriction to blood transfusion was necessary.
Keyphrases
- sars cov
- chemotherapy induced
- coronavirus disease
- respiratory syndrome coronavirus
- atrial fibrillation
- minimally invasive
- liver failure
- coronary artery bypass
- drug induced
- chronic kidney disease
- respiratory failure
- hepatitis b virus
- intensive care unit
- iron deficiency
- acute coronary syndrome
- coronary artery disease